140 related articles for article (PubMed ID: 23953169)
1. Differences in the acceptability of non-abstinence goals by type of drug among American substance abuse clinicians.
Rosenberg H; Davis AK
J Subst Abuse Treat; 2014 Feb; 46(2):214-8. PubMed ID: 23953169
[TBL] [Abstract][Full Text] [Related]
2. Acceptability of non-abstinence goals among students enrolled in addiction studies programs across the United States.
Davis AK; Lauritsen KJ
Subst Abus; 2016; 37(1):204-8. PubMed ID: 25774568
[TBL] [Abstract][Full Text] [Related]
3. Acceptance of non-abstinence goals by addiction professionals in the United States.
Davis AK; Rosenberg H
Psychol Addict Behav; 2013 Dec; 27(4):1102-9. PubMed ID: 23088408
[TBL] [Abstract][Full Text] [Related]
4. Treatment goals in addiction healthcare: the perspectives of patients and clinicians.
Joosten EA; De Weert-Van Oene GH; Sensky T; Van Der Staak CP; De Jong CA
Int J Soc Psychiatry; 2011 May; 57(3):263-76. PubMed ID: 20068024
[TBL] [Abstract][Full Text] [Related]
5. [Prospective study of favorable factors in follow-up of drug addicted patients--apropos of 257 patients of the Cassini Center in Paris].
Goeb JL; Coste J; Bigot T; Ferrand I
Encephale; 2000; 26(6):11-20. PubMed ID: 11217533
[TBL] [Abstract][Full Text] [Related]
6. Initial preference for drinking goal in the treatment of alcohol problems: II. Treatment outcomes.
Adamson SJ; Heather N; Morton V; Raistrick D;
Alcohol Alcohol; 2010; 45(2):136-42. PubMed ID: 20130150
[TBL] [Abstract][Full Text] [Related]
7. Acceptance and therapeutic practice of controlled drinking as an outcome goal by Swiss alcohol treatment programmes.
Klingemann H; Rosenberg H
Eur Addict Res; 2009; 15(3):121-7. PubMed ID: 19332990
[TBL] [Abstract][Full Text] [Related]
8. Initial preference for drinking goal in the treatment of alcohol problems: I. Baseline differences between abstinence and non-abstinence groups.
Heather N; Adamson SJ; Raistrick D; Slegg GP;
Alcohol Alcohol; 2010; 45(2):128-35. PubMed ID: 20130149
[TBL] [Abstract][Full Text] [Related]
9. Acceptance of Reduced-Risk Drinking as a Therapeutic Goal within the Polish Alcohol Treatment System.
Klingemann J
Alcohol Alcohol; 2016 Jul; 51(4):436-41. PubMed ID: 26861121
[TBL] [Abstract][Full Text] [Related]
10. Prospective validation of substance abuse severity measures from administrative data.
McCamant LE; Zani BG; McFarland BH; Gabriel RM
Drug Alcohol Depend; 2007 Jan; 86(1):37-45. PubMed ID: 16806738
[TBL] [Abstract][Full Text] [Related]
11. Acceptability and availability of harm-reduction interventions for drug abuse in American substance abuse treatment agencies.
Rosenberg H; Phillips KT
Psychol Addict Behav; 2003 Sep; 17(3):203-10. PubMed ID: 14498814
[TBL] [Abstract][Full Text] [Related]
12. Pattern of cannabis use in ecstasy polydrug users: moderate cannabis use may compensate for self-rated aggression and somatic symptoms.
Milani RM; Parrott AC; Schifano F; Turner JJ
Hum Psychopharmacol; 2005 Jun; 20(4):249-61. PubMed ID: 15816011
[TBL] [Abstract][Full Text] [Related]
13. Reduction in heavy drinking as a treatment outcome in alcohol dependence.
Gastfriend DR; Garbutt JC; Pettinati HM; Forman RF
J Subst Abuse Treat; 2007 Jul; 33(1):71-80. PubMed ID: 17588491
[TBL] [Abstract][Full Text] [Related]
14. Harm reduction for drug abusing ex-offenders: outcome of the California prevention and education project MORE project.
Bowser BP; Jenkins-Barnes T; Dillard-Smith C; Lockett G
J Evid Based Soc Work; 2010 Jan; 7(1):15-29. PubMed ID: 20178022
[TBL] [Abstract][Full Text] [Related]
15. [Sociodemographic profiles, addictive and mental comorbidity in cannabis users in an outpatient specific setting].
Guillem E; Pelissolo A; Vorspan F; Bouchez-Arbabzadeh S; Lépine JP
Encephale; 2009 Jun; 35(3):226-33. PubMed ID: 19540408
[TBL] [Abstract][Full Text] [Related]
16. Client matching: a severity-treatment intensity paradigm.
De Leon G; Melnick G; Cleland CM
J Addict Dis; 2008; 27(3):99-113. PubMed ID: 18956532
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of long-term residential substance abuse treatment for women: findings from three national studies.
Greenfield L; Burgdorf K; Chen X; Porowski A; Roberts T; Herrell J
Am J Drug Alcohol Abuse; 2004 Aug; 30(3):537-50. PubMed ID: 15540492
[TBL] [Abstract][Full Text] [Related]
18. A randomized controlled trial of a brief intervention for illicit drugs linked to the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) in clients recruited from primary health-care settings in four countries.
Humeniuk R; Ali R; Babor T; Souza-Formigoni ML; de Lacerda RB; Ling W; McRee B; Newcombe D; Pal H; Poznyak V; Simon S; Vendetti J
Addiction; 2012 May; 107(5):957-66. PubMed ID: 22126102
[TBL] [Abstract][Full Text] [Related]
19. Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study.
Peirce JM; Petry NM; Stitzer ML; Blaine J; Kellogg S; Satterfield F; Schwartz M; Krasnansky J; Pencer E; Silva-Vazquez L; Kirby KC; Royer-Malvestuto C; Roll JM; Cohen A; Copersino ML; Kolodner K; Li R
Arch Gen Psychiatry; 2006 Feb; 63(2):201-8. PubMed ID: 16461864
[TBL] [Abstract][Full Text] [Related]
20. Treating combined alcohol and drug abuse in community-based programs.
Hubbard RL
Recent Dev Alcohol; 1990; 8():273-83. PubMed ID: 2185522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
